F8 and hemophilia: The results from the Hemophilia Inhibitor Previously Untreated Patients (PUPs) Study (HIPS) demonstrated that the development of FVIII inhibitors within the first 50 exposure days (EDs) is associated with distinct antibody signatures (21).